GFRC Enhance Patient Satisfaction and Reduce Complications in Maxillary Implants With Pekkton Frameworks

NCT ID: NCT06581354

Last Updated: 2024-09-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

8 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2025-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the effect of provisionalization with a glass fiber composite framework on patient satisfaction and prosthetic complications before the insertion of a definitive PEKKTON framework when used under the screw-retained maxillary implant-supported prostheses at a one-year follow-up period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Patient grouping:

Group I: (intervention) Patients obtained an Implant-supported full arch maxillary provisional prosthesis protocol utilizing 6 implants for constructing a resin glass fiber composite framework followed by a definitive PEKKTON framework.

Group II: (control) patients obtained an Implant-supported, full arch maxillary definitive prosthesis utilizing 6 implants, for constructing PEKKTON framework without provisionalization.
2. Preparation of a scan appliance:

* The patient's denture will be used as a scan appliance by the addition of radiopaque material to act as radiopaque markers over the polished surfaces of the prosthesis in a staggered pattern at different levels to the occlusal plane on the buccal, labial, and palatal flanges of the denture.
* Double scan protocol will be used in our study in which a cone beam conventional tomography (CBCT) images will be produced for each case. The first scan will be taken for the maxilla while the patient is wearing the maxillary denture with the radiopaque markers and biting over cotton rolls, the other scan is for the modified maxillary denture.
* Computer software (BlueSky Bio) was used to overlap the two scans on each other where the final file contained reformatted images in 3D bone model, and 3D radiographic modified denture guide model to construct the surgical guide.
3. Virtual planning, surgical guide fabrication, and Implant placement

* The implant planning will be done using the BlueSky Bio software. The scan of the maxillary denture will be superimposed over that of the maxillary arch scan, using points over the radiopaque marker as alignment points, for proper orientation of the scan appliance.
* 6 Implant planning {(3.7x12) for the anterior segment and (4x10) for the posterior segment} will be placed in areas with high bone quality and quantity of bone and will be distributed according to AP spread.
* A surgical guide will be planned and then the 3D virtual guide will be exported as STL file to the 3D printing machine. The surgical guide will be fixed in place using three fixation screws; with an adequate distance from the planned implant drilling sites, two screws placed in the buccal shelf area on both sides, and one screw in the midline to achieve a tripoding position.
* The 3D surgical guide will be provided with metal sleeves corresponding to the virtually planned drilling sites with the precise depth, angulation, mesiodistal and buccolingual positioning of each implant as planned during the computer simulation for accurate placement of the implants' osteotomies. The osteotomies will be drilled, and implants will be inserted.
* The multi-unit abutments will be placed over the dental implants. The denture will be relieved around the abutments and picked up by soft liner.
* All patients will be instructed about oral hygiene measures, a soft diet for 4 weeks after surgery, and antimicrobial prophylaxes (amoxicillin 500mg twice daily for 5 days starting 1 hour before surgery). Postsurgical analgesic treatment will be performed with ibuprofen 600mg twice daily.
4. Prosthetic procedures: After 1 Month:

* Group one: will be rehabilitated by using a glass fiber composite as a temporary framework followed by PEKKTON definitive framework.

Framework fabrication:

* The glass fiber composite framework and PMMA teeth will be digitally designed according to implant location, crown height space, occlusion, and opposing complete denture with the help of scan appliance wax up.
* The framework will be placed over the multi-unit abutments intraorally, picked up on the cylinder and. The occlusion of printed teeth by PMMA will be checked and then cemented with the framework. Then the whole assembly will be removed from the patient's mouth.
* After one month, the printed composite framework with the printed PMMA teeth will be screwed intraorally.
* After four months of temporization, the definitive PEKKTON will be re-milled from the same scan and delivered to the patients with the milled teeth.
* These frameworks will be milled, the passive fit will be checked between frameworks and multi-unit abutments, and the occlusion of printed teeth by PMMA will be checked and tried intra-orally. If the try-in is accepted, the assigned material (PMMA) will be milled and assembled to the framework.
* Group two: patients obtained an Implant-supported, full-arch maxillary prosthesis utilizing 6 implants, for constructing PEKKTON framework without provisionalization.

A. Digital impressions Scan bodies will be tightened onto the multi-unit abutments and an intraoral digital impression will be made using an IOS system after one month of implant insertion.

B. Verification jigs fabrication (digitally) The milled PMMA jig will be constructed and checked for passive seating on implants by verifying proper contact at the PMMA jig interface and the multi-unit abutments.

C. Framework fabrication:

* The (PEKKTON) frameworks and teeth will be digitally designed according to implant location, crown height space, occlusion, and opposing dentition with the help of scan appliance wax up.
* The frameworks will be milled with the final material (PEKKTON) and teeth will be printed with temporary material (PMMA).
* First, the passive fit will be checked between frameworks and multi-unit abutments, and the occlusion of printed teeth by PMMA will be checked and tried intra-orally.
* Accordingly, if the try-in is accepted, the assigned material (PMMA) will be milled and assembled to the framework.
* Glass fiber composite (Trilor fiber disc) with 98mm diameter and 16mm height, bio-Loren company, made in Italy, 21047 saronno (va)Italy.
* PEKKTON ivory, High-performance polymer, Cendres +métaux

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Edentulous Alveolar Ridge

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Group I: Intervention will be treated using a glass fiber composite as a temporary framework followed by PEKKTON definitive framework.

Group II: Controls will be treated using PEKKTON definitive framework (no provisionalization).
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
The study will be based on different technical procedures for the fabrication of the frameworks. Since these differences are visible, the operator and the technician involved in the study as well as the outcome assessor cannot be blinded. But the statistician and patients will be blinded.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

no provisional prosthesis, pekkton is a definitive framework.

Implant-supported, full-arch maxillary prosthesis utilizing 6 implants, for constructing PEKKTON framework without provisionalization

Group Type ACTIVE_COMPARATOR

PROVISIONALIZATION

Intervention Type PROCEDURE

glass fiber composite as a temporary framework followed by PEKKTON definitive framework.

Glass fiber composite framework for provisionalization then pekkton framework.

Implant-supported full arch maxillary provisional prosthesis protocol utilizing 6 implants for constructing a resin glass fiber composite framework followed by a definitive PEKKTON framework.

Group Type EXPERIMENTAL

PROVISIONALIZATION

Intervention Type PROCEDURE

glass fiber composite as a temporary framework followed by PEKKTON definitive framework.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PROVISIONALIZATION

glass fiber composite as a temporary framework followed by PEKKTON definitive framework.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* a. Completely edentulous patients with Angle's Class I maxillomandibular relationship b. Age ranges from 40 to 65 years old. c. Adequate zone of keratinized attached mucosa (≥ 8mm) over the maxillary crest.

d. Absence of any medical disorder that could complicate the surgical phase or affect osseointegration.

e. The patient must have enough bone height for implants, a minimum length of bone f. 12 mm, and a minimum diameter of bone 6 mm. g. Patients with good oral hygiene. h. Complete denture wearer. i. Adequate interarch space for screw-retained prosthesis. j. Absence of any intra-oral pathological condition.

Exclusion Criteria

\- a. Patients with recent extraction (less than three months). b. Patients with an inflamed ridge or candida infection c. Patients with the flabby ridge. d. Para functional habits. e. Cancer patients receiving chemotherapy and/or radiotherapy. f. Patients with uncontrolled diabetes, assessed by measuring glycosylated hemoglobin (HbA1c ≥ 7) g. Potentially uncooperative patients who are not willing to go through the proposed interventions.

h. Moderate-to-heavy daily smokers (more than ten per day)
Minimum Eligible Age

40 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rana Mohamed Abdelhamed Shehata

principal investigator (assistant lecturer of prosthodontics)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

rana shehata, phd

Role: PRINCIPAL_INVESTIGATOR

faculty of dentistry Cairo university -Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

sheta

Role: CONTACT

+201224552363

Huda Fakhry, lecturer

Role: CONTACT

+201006229611

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2 1 24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.